William Blair Upgrades Insulet (PODD) to Outperform
More News related to PODD
- Insulet Corporation to Present at the Piper Jaffray Health Care Conference
- Insulet (PODD) Announces Pricing of 6M Common Share Offering at $10.25/Share
- Insulet Corporation Announces Pricing of Public Offering
- Morning Movers 10/29: ROIAK, GIGA, HS, TBL, KDN, CATM Higher; TSPT, CPF, CYTK, KSP, FSLR, CLUB, PODD Lower
- Insulet (PODD) to Offer 5.5M Common Shares
William Blair upgrades Insulet (Nasdaq: PODD) from Market Perform to Outperform.
To see more analyst ratings on PODD Click Here.
Insulet Corporation, a medical device company, engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes in the United States.
Related Categories
UpgradesStocks Mentioned
+0.02Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
